Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 34 Insulin Resistance 6 Infertility 5 Hyperandrogenism 3 Anovulation 3 Pre-Eclampsia 2 Metabolic Syndrome 2 Infertility, Female 2 Glucose Intolerance 2 Diabetes, Gestational 2 Carcinoma, Non-Small-Cell Lung 2 Weight Loss 1 Thyroid Nodule 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Premature Birth 1 Precancerous Conditions 1 Periodontitis 1 Oligomenorrhea 1 Lung Neoplasms 1 Inflammation 1 Colonic Neoplasms 1 Amenorrhea 1

Interventions

Exercise 5 Vitamin D 3 Resistance Training 3 Omeprazole 3 Etanercept 3 Dexmedetomidine 3 Ascorbic Acid 3 salicylsalicylic acid 2 palbociclib 2 epigallocatechin gallate 2 XENP 1595 2 Tea 2 Tablets 2 Sufentanil 2 Probiotics 2 Nutrition Assessment 2 Morphine 2 Metformin 2 Ketorolac 2 Infliximab 2 Ibuprofen 2 Fish Oils 2 Endurance Training 2 Colchicine 2 Aspirin 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × Inositol × Clear all

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡